< Zurück zu den aktuellen Neuigkeiten & Events

Neuigkeiten

Oral Proceedings before EPO Opposition Divisions – VC mandatory from January 2021 – will the Board of Appeal follow?

November 2020

On 10 November 2020 the EPO announced further measures in relation to the Pilot Project to allow opposition hearings to be held by videoconference (VC). Initially, the pilot project was to finish by April 2021. By a Decision of the President, this has now been extended until September 2021.

The full details of the how VC will work in the content of opposition oral proceedings can be found in the Decision of the President of the European Patent Office dated 10 November 2020 concerning the modification and extension of the pilot project for oral proceedings by videoconference before opposition divisions. The key points of the Decision to note are in Article 2:

  1. Oral proceedings before opposition divisions are held by videoconference.
  2. Notwithstanding paragraph 1, oral proceedings may be held on the premises of the European Patent Office, either at the request of a party or at the instigation of the opposition division if there are serious reasons against holding the oral proceedings by videoconference. If a request to hold oral proceedings on the premises of the European Patent Office is refused, the parties will be informed of the reasons; such a refusal is not separately appealable.
  3. Oral proceedings by videoconference are equivalent to oral proceedings held on the premises of the European Patent Office.

Accordingly, from 04 January 2021 it should be expected that the default position will be that Opposition oral proceedings will take place by videoconference.

As the current scheme allows one party to veto videoconference oral proceedings this is an unsurprising change given the increase in the backlog of cases that has built up over the past eight months. Indeed, the EPO has reported that uptake rate of the current “voluntary” scheme for VC oral proceedings has remained low whilst the backlog of unresolved opposition cases has built up with a “resulting loss in timeliness which is critical for access to justice”.

The parties to oral proceedings affected by the new measures will be informed by the EPO.

Regarding the Boards of Appeal, we understand that the President of the Boards of Appeal will soon launch a consultation concerning an amendment to its Rules of Procedure (RPBA) whereby a new rule (15A) will be introduced. The new rule allows a Board of Appeal to compel oral proceedings by videoconference, the draft text of which is as follows:

  1. The Board may decide to hold oral proceedings pursuant to A.116 EPC by videoconference if the Board considers it appropriate to do so, either upon request by a party or of its own motion.
  2. If oral proceedings are to be held by videoconference pursuant to paragraph (1), the Chair may order a party, representative or accompanying person to attend only remotely. The Chair may allow any member of he Board in the particular appeal to participate remotely. Any access to the videoconference shall be provided in real time.

According to some draft notes seen by HGF, examples of ‘appropriateness’ include (i) the suitability of the case, notably its complexity or the need for interpretation, (ii) the parties’ willingness to attend remotely, (iii) foreseeable travel restrictions and (iv) personal circumstances of the persons due to be involved. Markedly, the notes to A.15A(2) foresee an asymmetry in representation, whereby one party is present at the hearing and another party accesses the Hearing remotely.

The draft timetable for amendment of the RPBA is 01 April 2021 but it is said that Boards ‘may change their practice before that date’. Accordingly, HGF expect that the Boards will apply increased pressure on parties to conduct hearings by videoconference, especially if travel restrictions due to the pandemic continue.

This article was prepared by HGF Partner Dr Chris Moore. If you would like further advice on this or any other matter, please contact Chris. Alternatively, you can contact your usual HGF representative or visit our Contact page to get in touch with your nearest HGF office.

Aktuelle Neuigkeiten

The Antibody Series #4 | pH‑Werte in Antikörperansprüchen – wenn „gleicher pH‑Wert“ zur unzulässigen Erweiterung wird

          Die Beschwerdekammern des EPA (BoA) sind die Berufungsinstanz, die Entscheidungen des EPA überprüft. In diesem Fall befassten sie sich mit einer Entscheidung zur Widerrufung eines …

Weiterlesen

The Antibody Series #3 | Codenamen von Antikörpern in Ansprüchen: Warum „ACZ885” nicht ausreicht, um den Antikörper zu definieren

          Die Beschwerdekammern des EPA (BoA) sind die Berufungsinstanz, die Entscheidungen des EPA überprüft. In diesem Fall prüften sie einen Anspruch, der einen Antikörper anhand eines …

Weiterlesen

Agritech Thymes: Unlocking the Soil Microbiome: Driving Agritech Innovation in the UK

The UK offers an ideal platform for harnessing the untapped potential of soil and plant microorganisms. Although much of my professional experience has focused on the human microbiome, I have …

Weiterlesen

The Antibody Series #2 | Definition anhand der Bindungsstärke in Antikörperansprüchen: Wenn „binds strongly … but only minimally …“ zu einer Falle mangelnder Klarheit wird.

            Die Definition eines Antikörpers anhand seiner Bindungsstärke ist in Patentansprüchen gängige Praxis, kann jedoch im Hinblick auf Artikel 84 EPÜ zur Klarheit schnell zu …

Weiterlesen

The Antibody Series #1 | Qualitätsmerkmale (CQAs) in Antikörperansprüchen: Wenn die Testmethode aus dem Anspruch herausgenommen werden kann

            Therapeutische Antikörper stehen im Mittelpunkt der Innovationen in der Biotechnologie und im Gesundheitswesen. Angesichts steigender regulatorischer Anforderungen und Qualitätserwartungen werden kritische Qualitätsmerkmale (CQAs) bei …

Weiterlesen

EU Agrees on NGT Plant Regulation: What It Means for Patents and Licensing

The European Parliament and Council have reached a provisional agreement for plants developed using New Genomic Techniques (NGTs) – below we summarise the main points and set out the requirements …

Weiterlesen

When Retail Branding Meets Politics

(Inter IKEA Systems v Algemeen Vlaams Belang (Case C‑298/23) In November 2022, the Flemish political party Vlaams Belang presented its “IKEA-PLAN – Immigratie Kan Echt Anders” (“Immigration Really Can Be Different”). …

Weiterlesen

Büro geschlossen – Dezember 2025 / Januar 2026

HGF Büro geschlossen – Dezember 2025 / Januar 2026   UK Donnerstag, 25. und Freitag, 26. Dezember 2025 GESCHLOSSEN Donnerstag, 1. Januar 2026* GESCHLOSSEN * Freitag, 2. Januar 2026 – …

Weiterlesen